Monitor for any Form 4 filings indicating Armistice has exercised the options. If/when exercise occurs, expect substantial selling pressure as the holder can sell shares at a profit. The low exercise price relative to market suggests imminent exercise.
Price Chart
Executive Summary
InMed Pharmaceuticals amended preferred investment options held by Armistice Capital, reducing the exercise price from $16.60 to $0.80. This drastically increases the likelihood of exercise, which would bring significant dilution to existing shareholders. The move signals financial distress at the micro-cap company.
Key Financial Metrics
Key Facts
- Exercise price on 278,761 preferred investment option shares reduced from $16.60 to $0.80.
- Amendment entered into on May 18, 2026 with Armistice Capital Master Fund Ltd.
- Total potential dilution of up to 278,761 common shares if fully exercised.
- No new cash raised through this amendment.
- Company market cap is approximately $2M, making dilution material.
Financial Impact
Potential dilution of up to 278,761 shares or roughly doubling the current share count based on market cap.
Risk Factors
- Massive dilution to existing shareholders upon exercise.
- Potential near-term stock price decline from overhang of exercisable shares.
- Indication of financial distress and need for future capital.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001062993-26-002787 |
| Exhibit: exhibit99-1.htm | 0001062993-26-002787 |
| Document: form8k.htm | 0001062993-26-002787 |
| Document: 0001062993-26-002787-index-headers.html | 0001062993-26-002787 |
| Document: 0001062993-26-002787-index.html | 0001062993-26-002787 |
| Document: 0001062993-26-002787.txt | 0001062993-26-002787 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 425 | $1.31 $1.39 | ▲ +6.11% | ▲ +6.61% | $1.33 (+1.53%) |
Jul 10, 2026 12w ago | 8-K | $1.57 $1.52 | ▲ +3.18% | ▲ +2.40% | $1.33 (+15.29%) |
Jul 2, 2026 13w ago | S-4 | $1.56 $1.66 | ▼ −6.41% | ▼ −5.48% | $1.33 (+14.74%) |
Jun 11, 2026 16w ago | Insider Cluster | $1.58 $1.49 | ▼ −5.70% | ▼ −6.13% | $1.33 (−15.82%) |
Jun 10, 2026 16w ago | 8-K | $1.51 $1.48 | ▼ −1.99% | ▼ −5.42% | $1.33 (−11.92%) |
May 19, 2026 19w ago | 425 | $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.33 (−16.87%) |
May 19, 2026 19w ago | 8-K | $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.33 (−16.87%) |
May 19, 2026 19w ago | 8-K | $1.60 $1.66 | ▼ −3.75% | ▼ −1.45% | $1.33 (+16.87%) |
Apr 27, 2026 22w ago | 8-K | $0.7010 $0.7480 | ▼ −6.70% | ▼ −5.01% | $1.33 (−89.73%) |
Apr 3, 2026 26w ago | 8-K | $0.6950 $0.7130 | ▲ +2.59% | ▼ −1.54% | $1.33 (+91.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access